6月17日，赛默飞世尔盘中下跌3.1%，报458.845美元/股，成交额4.82亿美元。
消息面上，此前Piper Sandler将赛默飞世尔评级为中性，目标价510美元，汇丰银行亦将其评级从买入下调至持有、目标价从670美元降至540美元，多家机构持谨慎态度持续压制股价表现。当前股价已显著低于分析师平均目标价602.50美元。生命科学工具和服务板块整体走弱，同行业个股中艾昆纬跌4.7%、Adaptive Biotechnologies跌4.01%、丹纳赫跌2.49%、Tempus AI跌2.16%、沃特世跌1.3%，板块联动效应延续。
赛默飞世尔科技公司成立于1956年，是全球科学服务领域领先企业，通过旗下Thermo Scientific、Applied Biosystems、Invitrogen等品牌为制药、生物技术、医院及研究机构提供创新技术与服务。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.